3 completed, 3 terminated. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Terminated 3 |
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow Staphylococcal Protein A: new trials by email Literature Review of Staphylococcal Protein A trials Research Report on Staphylococcal Protein A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP PRTX-100 - Immune Thrombocytopenia | Phase 1 / Phase 2 | Terminated | Protalex, Inc. | 15 | 2015-11-01 | 2019-03-25 |
| PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP PRTX-100 - Immune Thrombocytopenia | Phase 1 / Phase 2 | Terminated | Protalex, Inc. | 13 | 2015-09-01 | 2019-07-05 |
| 6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection PRTX-100 - Arthritis, Rheumatoid | Phase 1 / Phase 2 | Completed | Protalex, Inc. | 13 | 2015-02-01 | 2018-10-16 |
| Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis PRTX-100 at 1.5 mcg/kg, PRTX-100 at 3.0 mcg/kg, PRTX-100 at 6.0 mcg/kg - Arthritis, Rheumatoid | Phase 1 | Completed | Protalex, Inc. | 61 | 2012-11-01 | 2014-12-23 |
| Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP PRTX-100 (Staphylococcal protein A) - Idiopathic Thrombocytopenic Purpura (ITP) | Phase 1 | Terminated | Protalex, Inc. | 9 | 2007-12-01 | 2018-07-20 |
| Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of PRTX-100 in Healthy Adult Volunteers PRTX-100 (Staphylococcal protein A) - Healthy Volunteers | Phase 1 | Completed | Protalex, Inc. | 20 | 2007-06-01 | 2008-05-06 |
Purpura, Thrombocytopenic, Idiopathic (3) · Arthritis, Rheumatoid (2) · Thrombocytopenia (2) · Arthritis (1) · Autoimmune Diseases (1) · Hematologic Diseases (1) · Hemostatic Disorders (1)
Protalex, Inc. (6)
United States (4) · United Kingdom (2) · Australia (1) · France (1) · New Zealand (1)
Charles H Ballow, PharmD (1) · Edward Bernton, MD (1) · John B McClain, MD (1) · William E Gannon Jr., MD (1) · William E Gannon, M.D. (1) · William E Gannon, MD (1)
2014 (1)